NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
fabio canforti
European Institute of Oncology Milan - Milan / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4686799
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
fabio canforti's MOST POPULAR ARTICLES
1-)
Cancer immunotherapy efficacy and patients\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\' sex: a systematic review and meta-analysisF Conforti, L Pala, V Bagnardi, T De Pas, M Martinetti, G Viale, RD Gelber, ...The Lancet Oncology 19 (6), 737-746, 20187432018
2-)
Talimogene laherparepvec (T-VEC): an intralesional cancer immunotherapy for advanced melanomaPF Ferrucci, L Pala, F Conforti, E CocorocchioCancers 13 (6), 1383, 20211632021
3-)
Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysisF Conforti, L Pala, V Bagnardi, G Viale, T De Pas, E Pagan, ...JNCI: Journal of the National Cancer Institute 111 (8), 772-781, 20191632019
4-)
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trialF Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ...Journal of translational medicine 18 (1), 405, 20201522020
5-)
Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapyPA Zucali, T De Pas, G Palmieri, A Favaretto, A Chella, M Tiseo, M Caruso, ...Journal of Clinical Oncology 36 (4), 342-349, 20181422018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept